Summary

US Ambulatory Cardiac Monitoring Devices Market is valued approximately USD 2.08 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 11.21% over the forecast period 2024-2032. Ambulatory cardiac monitoring devices are portable tools used to continuously record the heart's electrical activity while patients go about their daily lives. These devices, including Holter monitors, event monitors, mobile cardiac telemetry (MCT), and implantable loop recorders (ILR), are essential for diagnosing and managing heart conditions such as arrhythmias and unexplained fainting. They capture intermittent events that might be missed during short clinical exams, providing accurate data for early detection and prompt intervention. By allowing extended monitoring and patient mobility, these devices significantly improve the accuracy of cardiac diagnoses and treatments. The increase in integration of Artificial Intelligence (AI) is a key trend that is supporting the growth of the US Ambulatory Cardiac Monitoring Devices Market at a substantial rate. AI integration in monitoring devices is gaining traction. AI-driven algorithms enhance data analysis, enabling predictive insights, anomaly detection, and personalized patient care plans, thereby improving diagnostic accuracy and treatment outcomes.

The United States is positioned for substantial growth, driven by factors like the increasing prevalence of cardiovascular disease, rapid technological advancements, strong economic expansion, and supportive government initiatives. Additionally, the region's growth trajectory is bolstered by a surge in product approvals and launches. For example, in January 2022, Medilynx cardiac monitoring obtained a comprehensive patent in the US for continuous ECG streaming, analysis, and remote monitoring. Furthermore, in May 2021, Vital Connect Inc. unveiled its innovative cardiac monitoring patch, the VitalPatch RTM, designed for patients requiring extended Holter monitoring. Therefore, these advancements are anticipated to further stimulate US Ambulatory Cardiac Monitoring Devices Market growth over the forecast period. However, the stringent regulatory environment and high costs associated with ambulatory cardiac monitoring are expected to restrict market expansion over the estimate period of 2024–2032.


Major market player included in this report are:
Hill-Rom Services, Inc.
iRhythm Technologies, Inc.
Abbott Laboratories
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10



The detailed segments and sub-segment of the market are explained below:

By Type
ECG Devices
Holter Monitors
Event Monitors
Implantable Loop Recorders
Mobile Cardiac Telemetry

By End-use
Ambulatory Care Centers
Hospitals & Clinics
Others


Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. US Ambulatory Cardiac Monitoring Devices Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. US Ambulatory Cardiac Monitoring Devices Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Type
2.2.2. By End-use
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
Chapter 3. US Ambulatory Cardiac Monitoring Devices Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. US Ambulatory Cardiac Monitoring Devices Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. US Ambulatory Cardiac Monitoring Devices Market Size & Forecasts by Type 2022-2032
5.1. ECG Devices
5.2. Holter Monitors
5.3. Event Monitors
5.4. Implantable Loop Recorders
5.5. Mobile Cardiac Telemetry
Chapter 6. US Ambulatory Cardiac Monitoring Devices Market Size & Forecasts by End-use 2022-2032
6.1. Ambulatory Care Centers
6.2. Hospitals & Clinics
6.3. Others
Chapter 7. Competitive Intelligence
7.1. Key Company SWOT Analysis
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Hill-Rom Services, Inc.
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. iRhythm Technologies, Inc.
7.3.3. Abbott Laboratories
7.3.4. Company 4
7.3.5. Company 5
7.3.6. Company 6
7.3.7. Company 7
7.3.8. Company 8
7.3.9. Company 9
7.3.10. Company 10
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes